Usted buscó: el mao (Danés - Inglés)

mao
mao zedong

mao zedong
zedong

mao-hæmmere
mao inhibitors

monoaminooxidasehæmmere (mao- hæmmere):
monoamine oxidase inhibitors:

med behandling med mao- inhibitorer.
after discontinuation of mao inhibitor therapy.

hr. corbett citerede formand mao.
mr corbett quoted chairman mao.

rocca dei corvi - mao - mortou
rocca dei corvi — mao — mortou

dernæst alligevel nej til mao tse-tung.
these are things which touch us to the core.

ikke-selektive mao-hæmmere og mao -
non-selective mao-inhibitors and mao-inhibitors

hæmmere og ikke-selektive mao hæmmere) .
inhibitors, or non-selective mao-inhibitors) .

paroxetin er kontraindiceret i kombination med mao- hæmmere.
paroxetine is contraindicated in combination with monoamine oxidase inhibitors (maois).

mao - inhibitorer er derfor relativt kontraindiceret med remeron.
mao-inhibitors are therefore relatively contra-indicated with remeron.

metformin tetracykliner salicylater og p-aminosalicylsyre mao-hæmmere
metformin, tetracyclines, salicylates and p-amino-salicylic acid, mao-inhibitors,

mao- hæmmere (brugt til behandling af depression).
mao-inhibitors (used to treat depression).

-fluoxetin, mao-hæmmere (til behandling af depression)
-fluoxetine, mao-inhibitors (to treat depression)

fæokromocytom behandling med non-selektive monoaminoxidasehæmmere (mao-hæmmere)
treatment with non-selective mono amino oxidase (mao) inhibitors

irreversible, selektive mao-b-hæmmere (selegilin, rasagilin)
irreversible, selective mao-b inhibitor (selegiline, rasagiline)

mao- hæmmere kaldet mao- a- hæmmere (for eksempel moclobemid).
however treatment with fluoxetine can be started the following day after discontinuation of certain maois called reversible maoi-a (for instance moclobemide)

monoaminooxidase-hæmmere (mao-hæmmere) (til behandling af depression)
monoamine oxidase inhibitors (maoi) (used to treat depression)

-mao-hæmmere (se pkt.4. 5) .leversygdomme resulterende i nedsat leverfunktion (se pkt.5. 2) .
liver disease resulting in hepatic impairment (see section 5.2) .